Objective: To determine outcomes for both donors and recipients of adult-to-adult living donor liver transplantation (AALDLT) and independent factors impacting those outcomes. Summary Background Data: Deceased donors for organ transplantation remain extremely rare, making living donor liver transplantation (LDLT) practically the sole therapeutic modality for patients with end-stage liver disease in Japan. Methods: Retrospective analysis of initial LDLT for 335 consecutive adult (Ն18 years) patients performed between November 1994 and December 2003. Results: Of the 335 recipients, 275 received right-liver grafts and the remaining 60 recipients received non-right-liver grafts. Three of the 335 liver grafts were domino-splitting livers. Sixty of the 332 donors other than the domino-donors showed major postoperative complications. Multivariate analysis indicated that accumulation of case experience significantly and advantageously affected the surgical outcomes of these living liver donors, and right-liver donation and prolonged donor operation time were shown to be independent risk factors of major complications in the donors. Post-transplant patient and graft survival estimates were 73.1% and 72.5% at 1 year, 67.7% and 66.3% at 4 years, and 64.7% and 61.9% at 7 years, respectively. Obvious pretransplant encephalopathy, a higher (Ն31) modified Model for End-stage Liver Disease score (including points for persistent ascites and low serum sodium) and higher donor age (Ն50 years) were indicated as independent factors predictive of graft failure (graft loss or death) in the multivariate analysis. Conclusions: Graft type and degree of experience exerted a significant impact on the surgical outcomes of AALDLT donors but did not significantly affect the survival outcomes of AALDLT recipients. Better pretransplant conditions and younger age (Ͻ50 years) among the living donors appeared to be advantageous in terms of gaining better survival outcomes of patients undergoing AALDLT. (Ann Surg 2007;245: 315-325) 
D
uring the past 2 decades, the number of cases of liver transplantation (LT) using deceased donor livers has steadily increased, [1] [2] [3] [4] whereas the shortage of deceased donor organs has been a worldwide problem. 5, 6 Unlike countries that can perform LT using deceased donors, [1] [2] [3] [4] [5] [6] various cultural, social, and historic backgrounds in Japan have severely limited the availability of deceased-donor organs and forced us to perform LT using living donors. [7] [8] [9] Living donor liver transplantation (LDLT) was initially introduced to overcome the severe shortage of size-matched deceased livers for pediatric recipients, and has helped to reduce mortality among patients on the pediatric waiting list. 10 -13 In the early 1990s in Japan, LDLT was applied only to pediatric patients. [7] [8] [9] However, the severely limited availability of deceased donor organs compelled Japanese liver transplant surgeons to begin performing adult-to-adult LDLT (AALDLT), 7-9,14 -16 and the first successful LDLT in an adult recipient was performed in Japan in 1994. 7 Since then, although AALDLT has been vigorously performed worldwide, [2] [3] [4] [5] [6] [7] [8] [9] there has yet to emerge a clear advantage of AALDLT over deceased donor LT (DDLT) for adult patients, beyond the obvious expansion of the donor pool. 3, 4 Although the use of deceased donors has been approved legally since 1997 in Japan, 8, 9 the availability of deceased donors remains very rare. Therefore, LDLT remains practically the sole therapeutic modality for patients with end-stage liver disease (ESLD) in Japan. 8, 9 Between June 1990 and December 2003, we performed 957 LDLTs for 914 patients. Of these, 335 patients were adults (aged 18 years or more). In the present study, these 335 consecutive initial AALDLTs were evaluated to determine both donor and recipient outcomes. Our review assessed the surgical outcomes of the liver donors, risk factors of livingliver-donor morbidity, survival outcomes of recipients, and independent prognostic factors for post-transplant patient/ graft survival.
MATERIALS AND METHODS
Our AALDLT program was initiated in November 1994 with the experience of over 100 pediatric LDLT cases. 9,14 -16 In the early years of our AALDLT program (November 1994 to January 1998), we used left-sided liver grafts only ͓left lateral-section graft (LLS), segments II-III, according to Couinaud's nomenclature for liver segmentation, or left-liver graft (LL), segments II-IV͔. However, the early outcomes of our AALDLT program were disappointing due to the small-for-size graft problem. 9,14 -17 As a result, as of February 1998, we began performing LDLT using a right-liver graft ͓RL, segments V-VIII without the middle hepatic vein (MHV) trunk͔. 16 Then, the left-liver-plus-caudate-lobe graft (LLCL, segments I-IV), 18 extended rightliver graft (ExRL, segments V-VIII with MHV trunk), 19 right lateral-sector graft (RLS, segments VI-VII) 20 have been included into our repertoire of liver-graft types. Between November 1994 and December 2003, we performed an initial LDLT on 335 consecutive adult patients. Donors and recipients of these 335 AALDLT cases were included in this study. Although 12 of the 335 recipients underwent a second LDLT for reasons of graft failure due to various causes, these 12-second LDLTs were excluded from this study because the donor selection for the second LDLT was more medically and/or socially complicated than that for the initial LDLT, and because the sample size for the second LDLT was small.
Donors
Our standard donor selection criteria have been described in detail elsewhere. 16, 21, 22 In brief, the primary selection criterion for a living liver donor was voluntary and informed consent clearly stating that living liver donation can lead to donor mortality or residual disability. Apart from informed consent, the potential living donors had to fulfill the following acceptance criteria: 1) a relationship with the recipient within the third degree of consanguinity or intensive emotional relationship; and 2) no known medical disorder that significantly increased the perioperative risk or contraindicated donation. Computed tomography (CT) scan for 14 volumetric size measurement was performed to evaluate graft size, size of the future remnant donor liver, and hepatic vascular anatomy. Exclusion criterion for living liver donation was a remnant liver volume of less than 30% of the total liver volume estimated by the CT volumetry. In each case, our institutional LDLT indication committee was the final judge of whether a living donor candidate received approval. The detailed surgical technique for living liver donation has been described elsewhere. 16,18,19 -22 We examined the demographic data, biomedical characteristics, operation-related variables, and clinical course, including postoperative complications, of the 335 AALDLT donors. Postoperative donor complications were defined as follows. A minor complication was considered as any complication that was not life-threatening, did not result in residual disability, and did not require either surgical or radiologic/endoscopic intervention. A major complication was any complication that was potentially life-threatening, could lead to residual disability, and/or required surgical and/or radiologic/endoscopic intervention. The sole death to date of a living liver donor in Japan occurred at our institution, as previously reported. 23 The donor died due to a posthepatectomized hepatic failure caused by an ExRL donation combined with originally underlying nonalcoholic steatohepatitis. The donor who died was employed for a second LDLT, which was performed on an 18-year-old woman who had undergone initial LDLT for biliary atresia 8 years prior. Therefore, the donor who died was not included in this study.
Patients
Exclusion criteria of patients for LDLT were the following: 1) ongoing active infection, 2) uncontrolled extrahepatic malignancy, or 3) hepatic malignancy involving the major hepatic vascular branches. The LDLT surgical technique has been described in detail elsewhere. 16,18,19 -22 With respect to biliary reconstruction, hepaticojejunostomy with a Roux limb was used routinely for biliary reconstruction until June 1999. Since July 1999, duct-to-duct anastomosis has been the preferred biliary tract reconstruction technique, unless recipient duct length and vascularity made it technically inadequate. 24 We investigated the pretransplant patient characteristics of the 335 AALDLT recipients, including original liver disease indicating LDLT, Model for End-stage Liver Disease (MELD) score, 25 calculated with the most recent blood test results available at the time of LDLT, encephalopathy stage defined by Trey and Davidson, 26 status of LDLT (nonurgent or urgent), and relationship of donors to their respective recipients. Other examined features included the following: ABO-blood group combination, operating time (min), intraoperative blood loss (mL), cold ischemic time (CIT, min), warm ischemic time (WIT, min), graft type, actual graft weight weighed just after flushing with preservation solution (g), actual graft-to-recipient weight ratio (AGRWR, %) calculated by the following equation: {(actual graft weight ͓g͔)/(patient body weight ͓g͔)} ϫ 100 (%), anatomic variations of graft liver, presence of hepatocellular carcinoma (HCC) in the explanted native liver, whether or not the histologic tumor characteristics of HCC met the Milan Criteria (single nodule Ͻ5 cm, or 3 or fewer nodules and maximum tumor Ͻ3 cm) 27 if HCC was present, postoperative complications, and survival outcomes. In addition, the presence of persistent ascites and low serum sodium (Ͻ135 mEq) in the pretransplant period was reviewed because it was very recently reported that persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. 28 To be classified as persistent, ascites (and/or hydrothorax) had to be of at least moderate severity despite diuretic treatment and confirmed by current imaging studies or recent paracentesis or thoracocentesis. We also reviewed a modified MELD score (MELD-AS score, calculated by the following formula: MELD score ϩ 4.53x (serum sodium Ͻ135 mEq/L ͓absent, 0; present, 1͔) ϩ 4.46x (persistent ascites ͓absent, 0; present, 1͔), 28 by including points for persistent ascites and low serum sodium. With regard to the stage of encephalopathy, 26 stage I encephalopathy was usually indistinguishable and thus disregarded. Hepatic encephalopathy of a severity of at least stage II was recorded as obvious encephalopathy.
Urgent LDLT was defined as LDLT performed for patients who required both intensive care unit management and artificial liver support, including plasma exchange and/or continuous/intermittent hemodiafiltration in the pretransplant period. The MELD and MELD-AS scores were not recorded in urgent cases because all urgent-status patients received 
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Adult-to-Adult LDLT artificial liver support treatment; thus, prothrombin time as well as serum levels of total bilirubin, creatinine, and sodium were modified in these patients. Acute or chronic rejection was diagnosed histologically according to the Banff schema 29 in principle, although some episodes were diagnosed clinically because liver biopsy was regarded as risky or unnecessary.
Immunosuppression
Immunosuppressive treatment consisted of tacrolimus and low-dose corticosteroids. 30 Supplemental immunosuppression, when required, consisted of azathioprine, mizoribine, or mycophenolate mofetil with or without occasional induction therapy with monocronab-CD3. Patients who received blood-type-incompatible transplants had preoperative plasma exchange or double filtration plasmapheresis to reduce the anti-ABH antibody titer. Prostaglandin E1, cyclophosphamide, and additional corticosteroids were administered from the portal vein or hepatic artery postoperatively.
31,32

Statistical Analyses
Follow-up was continued until March 2005 or until graft loss and/or death. To identify the risk factors for major postoperative complications of the donors, variables concerning the living donors were assessed univariately by nonparametric methods. Variables found to be significantly (P Ͻ 0.05) associated with major complications in donors by univariate analyses or thought to be important based on logical and/or biomedical grounds were entered into a binary logistic regression analysis to determine the independent risk factors for postoperative major complications in donors. The goodness-of-fit of the logistic regression analysis was evaluated by the Hosmer-Lemeshow test.
Post-transplant recipient survival curves were computed using Kaplan-Meier methods and compared using the Breslow-Gehan-Wilcoxon test. For univariate screening purposes, continuous variables were polychotomized at clinically significant thresholds to form 2 or more groups. All variables found to be univariately significant at P Ͻ 0.10 or those thought to be important for logical and/or biomedical grounds were entered into a backward step-down Cox proportional-hazard regression analysis to determine the independent prognostic factors for graft failure (graft loss or death). The methods of May and Hosmer were used to compute overall goodness-of-fit 2 measures for the final Cox models. All statistical evaluations were performed using the FIGURE 1. Differences in mode of donor hepatectomy and incidence rate of major complications in donors according to case experience. When the study population was divided into 3 groups based on case experience (group 1, cases 1-100; group 2, cases 101-200; and group 3, cases 201-335), Non-right-liver donation decreased as case experience increased. The rate of incidence of major complications among donors was highest in group 2 (22%), lowest in group 3 (16%), and intermediate in group 1 (17%). Non-RL, non-right-liver donation; RL, right hepatectomy; ExRL, extended right hepatectomy. 
RESULTS
Donor Outcomes Demographics and Operative Variables of the Living Liver Donors
Donor demographics and operative variables are summarized in Table 1 . Of the 335 living donors, 3 graft livers were obtained by the domino-splitting liver method as previously reported. 33 Variables concerning these 3 dominosplitting liver grafts were excluded from the statistical analyses of donor intraoperative and postoperative variables. Over 80% of the donors underwent right-liver donation. Resection volume of donor hepatectomy, calculated as {(actual graft weight ͓g͔)/(estimated total donor liver volume by preoperative CT volumetry ͓ml͔) ϫ 100 (%), ranged from 20.3% to 86.1% with a median of 55.1%. Resection volume exceeded 70% in 14 living liver donors.
Postoperative Complications of the Living Donors
The observation period ranged from 16 to 125 months, with a median of 53 months. Of the 332 living donors, 133 developed one or more postoperative complications (Table 2) , for an occurrence rate of overall complications of 39.7%. The most frequent major complication was bile leakage requiring percutaneous and/or radiologic/endoscopic drainage. Receliotomy was required for 7 living donors. Operative methods for these receliotomies included hepaticojejunostomy using a Roux limb for biliary stricture in 3 cases, surgical retrieval of intestinal obstruction in 2, surgical thrombectomy for portal vein thrombosis in 1, and removal of a remaining intra-abdominal drainage tube in the abdomen in 1. Of the 7 living donors who developed biliary stricture, all 7 required balloon dilatation and/or temporary stent placement under retrograde endoscopic cholangiography, and 3 of the 7 required the above-mentioned surgical interventions. The next most-frequent major complication was pulmonary embolism, which was observed in 5 of the 332 living donors. Fortunately, all 5 recovered with conservative thrombolytic treatment. Thereafter, they were maintained with anticoagulants and are currently no longer receiving anticoagulant treatment. Depressive illness, which was difficult to classify as a major or minor complication and thus was excluded from the statistical analyses, was observed in the early postoperative period in 2 donors.
When the study population was divided into 3 groups based on case experience (group 1, cases 1-100; group 2, cases 101-200; and group 3, cases 201-335), the rate of incidence of major complications in the donors was highest in group 2, lowest in group 3, and intermediate in group 1 (Fig. 1) .
No mortality was observed in these 332 living donors. Fortunately, no complications have led to residual disability, and all of the 332 donors are currently doing well and leading normal daily lives.
Risk Factors for Postoperative Major Complications Among Living Donors
Variables that were significantly (P Ͻ 0.05) different in the univariate analyses between living donors with and without major postoperative complications were body mass index (BMI), mode of donor hepatectomy (non-right liver, RL, or 
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Adult-to-Adult LDLT ExRL), resection volume of donor hepatectomy (Ͻ50% or Ն50%), and operating time (Յ360 minutes or Ն361 minutes). The results of the logistic regression analysis to identify independent factors predictive of postoperative donor major complications are shown in Table 3 . Accumulation of case experience independently reduced the risk of major complications. Right-hepatectomy or extended right-hepatectomy had a significantly more disadvantageous impact on major complications than did non-right-hepatectomy. Prolonged operating time (Ն361 minutes) was also significantly associated with major complications.
Recipient Outcomes Demographics and Surgical Outcomes of the 335 Recipients
Demographic data of the 335 patients and original disease prompting LDLT are shown in Table 4 . Urgent LDLT was conducted in 74 patients. Ninety patients had HCC. Of these 90, 36 met the Milan Criterian, whereas the remaining 54 did not. Fifty-three patients received a small-for-size graft (AGRWR Ͻ0.8%). Anatomic variations affecting the operative procedures were observed in some liver grafts: Multiple bile-duct orifices had to be reconstructed in 99 grafts; multiple hepatic veins in 132, and multiple portal-vein orifices in 24 ( Table 4) . The most frequent complication was infection regardless of severity (57.9%). The second most-frequent complication was acute rejection (33.1%), followed by biliary complication (32.8%). Eighty-four (25.1%) of the 335 primary transplants resulted in early graft loss within 6 post-transplant months.
Differences in the demographic data, intraoperative variables, and postoperative complications based on case experience (group 1, cases 1-100; group 2, cases 101-200; and group 3, cases 201-335) are summarized in Table 5 . Of these variables, patient age, number of urgent-status patients, number of patients with obvious encephalopathy, the ratios of female and male patients, operating time, and AGRWR differed significantly among the 3 groups. The remaining intraoperative variables were similar among the 3 groups.
The occurrence rate of most post-transplant complications was similar among the 3 groups. However, the occurrence rate of bile leakage and fungal infection significantly decreased in the following order: group 1, 2, and 3 ( Table 5 ). The postoperative observation period range was 0.1 to 124.5 months with a median of 34.5 months. Overall post-transplant cumulative patient and graft survival estimates were 73.1% and 72.5% at 1 year, 67.7% and 66.3% at 4 years, and 64.7% and 61.9% at 7 years (Fig. 2) , respectively. When the 3 groups were compared based on case experience, the cumulative post-transplant survival estimates were significantly better in group 3 than in group 1 (Fig. 3) . However, no statistically significant differences in post-transplant survival estimates were observed between groups 1 and 2, nor between groups 2 and 3 (Fig. 3) .
The presence of obvious pretransplant encephalopathy and urgent LDLT-status exerted the most significant effects on post-transplant survival estimates (P Ͻ 0.0001) (Fig. 4A,  B) . The next most-significant variables impacting post-transplant survival were graft type (P ϭ 0.0038) (Fig. 4C) and MELD-AS score (P ϭ 0.0075) (Fig. 4D ).
Independent Prognostic Factors for Post-transplant Patient/Graft Survival
Twenty-four variables, including patient age, patient gender, patient BMI, obvious pretransplant encephalopathy, MELD score (Յ25 or Ն26), pretransplant persistent ascites, MELD-AS score (Յ30 or Ն31), status of LDLT (nonurgent or urgent), presence of HCC in the explanted liver, whether or not the tumor characteristics of HCC met the Milan Criteria in cases of HCC, recipient operation time, recipient intraoperative blood loss, CIT, WIT, AGRWR, graft type (non-rightliver or right-liver), method of biliary reconstruction, number of orifices in the graft portal vein or hepatic vein (single or multiple), use of ABO-incompatible liver graft, donor age (Ͻ50 years or Ն50 years), blood relationship between donors and recipients, donor BMI, and case experience, were entered into a backward step-down Cox proportional-hazard regression analysis to identify independent factors predictive of graft failure. As a result, the presence of obvious pretransplant encephalopathy, higher MELD-AS scores, and higher donor age were indicated as independent factors predictive of graft failure (Table 6 ). FIGURE 2. Post-transplant cumulative patient and graft survival estimates after adult-to-adult living donor liver transplantation at Kyoto University. Post-transplant cumulative patient and graft survival estimates were 73.1% and 72.5% at 1 year, 67.7% and 66.3% at 4 years, and 64.7% and 61.9% at 7 years, respectively. FIGURE 3. Differences in post-transplant survival estimates based on case experience. When the patient population was divided into 3 groups based on case experience (group 1, cases 1-100; group 2, cases 101-200; and group 3, cases 201-335), the cumulative post-transplant survival estimates were significantly (P Ͻ 0.05) better in group 3 than in group 1. However, differences in post-transplant survival estimates between groups 1 and 2 and between groups 2 and 3 did not achieve statistical significance.
DISCUSSION
To date, our institution has carried out more than 1000 cases of LDLT procedures, including AALDLT as well as pediatric LDLT. 9 The first case of AALDLT at our institution was the 140th case of our LDLT program; during the present study period, we simultaneously performed more than 500 cases of pediatric LDLT along with the 335 AALDLT cases.
Furthermore, we first used right-liver donation 16 for case 38 of the 335 patients enrolled in the present study. Namely, we obtained sufficient level of surgical and case management experience with pediatric LDLT as well as AALDLT cases; thus, case experience did not independently affect recipient outcomes in this series. Right-liver donation was used for over 80% of the 335 AALDLT cases, and the present series reflects most of our experience with right-liver donation. Thus, case experience was found to independently affect the surgical outcomes of the present liver donors. Apart from case experience, however, RL or ExRL donation independently also increased the risk of major postoperative complications in the living donors. The finding that RL or ExRL donation was an independent risk factor for major postoperative complications in donors corroborated with experience showing that the application of living donation to the adult recipient population adds yet another layer of difficulty to an already challenging procedure; furthermore, this finding reemphasized that living RL or ExRL donation must be more carefully performed than other types of graft. On the other 34 Indeed, the Tokyo University Group demonstrated that the survival outcomes of AALDLT recipients of non-right-liver grafts were significantly superior to those of recipients of RL or ExRL grafts. 34 The MELD score, which has been used for allocating liver grafts in DDLT in the United States, 6, 25 has been reported to precisely predict death before implementation of LT in patients with ESLD, 25, 28 but it has not been shown to predict posttransplant survival outcomes. 4, 35, 36 The present study demonstrated that both obvious pretransplant encephalopathy and the MELD-AS score could predict post-transplant survival outcomes. Namely, encephalopathy, grade of ascites, low serum sodium, as well as other variables, any of which can be affected by the severity of ESLD but are not included as components determinative of the MELD score, should be taken into consideration when determining the optimal timing of LT. Furthermore, higher donor age (Ն50 years) was confirmed to be an independent factor predictive of graft failure by the final Cox model in the present study. These results suggest that patients without obvious pretransplant encephalopathy, patients with a MELD-AS score Յ30, and the use of younger donors (Ͻ50 years) are preferred for obtaining better outcomes among AALDLT recipients. Importantly, meticulous pretransplant patient evaluation to determine the optimal timing of LT and careful donor selection may provide better survival outcomes of AALDLT. Because the opportunity to schedule surgery is one of the biggest advantages of LDLT over DDLT, a meticulous patient and donor selection process may be the most immediate and dramatic way to improve survival outcomes of AALDLT recipients.
CONCLUSION
Case experience and technical refinement of the transplant team are undoubtedly very important for obtaining better outcomes among both donors and recipients of AALDLT. However, once sufficient levels of case experience and technical refinement have been achieved, meticulous pretransplant patient evaluation assures earlier and elective AALDLT, thereby reducing metabolic demands for successful transplantation; cases of futile transplantation may thus be avoided, while careful donor selection to avoid RL or ExRL donation whenever possible could lead to a decrease in the operative risks to AALDLT donors.
